Patents by Inventor Zoi Karoulia

Zoi Karoulia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating CDK4/6-mediated cancer
    Patent number: 11541051
    Abstract: Methods for designing heterobifunctional small molecules which selectively degrade/disrupt CDK4/6 and compositions and methods of using such degraders/disruptors to treat CDK4/6-mediated cancer are provided.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: January 3, 2023
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Jian Jin, Xiaobao Yang, Jing Liu, Yan Xiong, Poulikos Poulikakos, Zoi Karoulia, Xuewei Wu, Tamer Ahmed
  • Compositions and methods for treating CDK4/6-mediated cancer
    Patent number: 11285150
    Abstract: Methods for designing heterobifunctional small molecules which selectively degrade/disrupt CDK4/6 and compositions and methods of using such degraders/disruptors to treat CDK4/6-mediated cancer are provided.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: March 29, 2022
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Jian Jin, Xiaobao Yang, Jing Liu, Yan Xiong, Poulikos Poulikakos, Zoi Karoulia, Xuewei Wu, Tamer Ahmed
  • COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER
    Publication number: 20220054488
    Abstract: Methods for designing heterobifunctional small molecules which selectively degrade/disrupt CDK4/6 and compositions and methods of using such degraders/disruptors to treat CDK4/6-mediated cancer are provided.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Jian Jin, Xiaobao Yang, Jing Liu, Yan Xiong, Poulikos Poulikakos, Zoi Karoulia, Xuewei Wu, Tamer Ahmed
  • COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER
    Publication number: 20190336503
    Abstract: Methods for designing heterobifunctional small molecules which selectively degrade/disrupt CDK4/6 and compositions and methods of using such degraders/disruptors to treat CDK4/6-mediated cancer are provided.
    Type: Application
    Filed: December 7, 2017
    Publication date: November 7, 2019
    Inventors: Jian Jin, Xiaobao Yang, Jing Liu, Yan Xiong, Poulikos Poulikakos, Zoi Karoulia, Xuewei Wu, Tamer Ahmed